1型糖尿病中糖尿病神经病变的当代患病率:来自T1D Exchange的发现
在美国T1D Exchange临床注册研究中,对病程≥5年的1型糖尿病成人采用密歇根神经病变筛查量表问卷(MNSIQ)评估糖尿病周围神经病变(DPN),评分≥4分定义为DPN。在5936名参与者中DPN患病率为11%,低于既往报告;DPN与更年长、更高HbA1c、更长病程、女性、较低社会经济地位及心血管疾病风险因素等相关。
要点
- 在T1D Exchange的5936名1型糖尿病成人中,DPN患病率为11%。
- DPN参与者更年长、HbA1c更高、病程更长,女性比例更高,大学教育和私人保险比例更低(均P<0.001)。
- DPN参与者更常合并心血管疾病、吸烟、高甘油三酯血症、更高BMI、视网膜病变、eGFR降低及Charcot神经关节病。
核心结论
- 该全国性1型糖尿病队列中DPN患病率为11%,低于既往已发表报告,但反映了当前临床诊疗实践。
- 数据还强调非血糖风险因素,如心血管疾病风险因素、严重低血糖、糖尿病酮症酸中毒和较低社会经济地位,也可能在DPN发生中起作用。
研究设计与样本
- 研究为在美国T1D Exchange临床注册研究中评估1型糖尿病参与者DPN的当代患病率。
- 采用密歇根神经病变筛查量表问卷(MNSIQ)对病程≥5年的1型糖尿病成人进行评估,评分≥4分定义为DPN。
- 分析了人口学、临床和实验室因素与DPN的关联。
- 共纳入5936名T1D Exchange参与者,平均±SD年龄39±18岁,1型糖尿病病程中位数18年(四分位距11,31),女性55%,非西班牙裔白人88%,平均糖化血红蛋白(HbA1c)8.1±1.6%(65.3±17.5 mmol/mol)。
主要发现
- DPN患病率为11%。
- 与无DPN者相比,DPN参与者更年长、HbA1c更高、糖尿病病程更长、女性比例更高、大学教育比例更低、私人保险比例更低(均P<0.001)。
- DPN参与者更常合并心血管疾病(CVD)(P<0.001),以及更差的心血管疾病风险因素:吸烟(P=0.008)、高甘油三酯血症(P=0.002)、更高BMI(P=0.009)、视网膜病变(P=0.004)、估算肾小球滤过率降低(P=0.02)和Charcot神经关节病(P=0.002)。
- 胰岛素泵或连续血糖监测仪使用无差异,但DPN参与者过去3个月内更常发生严重低血糖(P=0.04)和/或糖尿病酮症酸中毒(P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the contemporary prevalence of diabetic peripheral neuropathy (DPN) in participants with type 1 diabetes in the T1D Exchange Clinic Registry throughout the U.S. RESEARCH DESIGN AND METHODS: DPN was assessed with the Michigan Neuropathy Screening Instrument Questionnaire (MNSIQ) in adults with ≥5 years of type 1 diabetes duration. A score of ≥4 defined DPN. Associations of demographic, clinical, and laboratory factors with DPN were assessed. RESULTS: Among 5,936 T1D Exchange participants (mean ± SD age 39 ± 18 years, median type 1 diabetes duration 18 years [interquartile range 11, 31], 55% female, 88% non-Hispanic white, mean glycated hemoglobin [HbA1c] 8.1 ± 1.6% [65.3 ± 17.5 mmol/mol]), DPN prevalence was 11%. Compared with those without DPN, DPN participants were older, had higher HbA1c, had longer duration of diabetes, were more likely to be female, and were less likely to have a college education and private insurance (all P < 0.001). DPN participants also were more likely to have cardiovascular disease (CVD) (P < 0.001), worse CVD risk factors of smoking (P = 0.008), hypertriglyceridemia (P = 0.002), higher BMI (P = 0.009), retinopathy (P = 0.004), reduced estimated glomerular filtration rate (P = 0.02), and Charcot neuroarthropathy (P = 0.002). There were no differences in insulin pump or continuous glucose monitor use, although DPN participants were more likely to have had severe hypoglycemia (P = 0.04) and/or diabetic ketoacidosis (P < 0.001) in the past 3 months. CONCLUSIONS: The prevalence of DPN in this national cohort with type 1 diabetes is lower than in prior published reports but is reflective of current clinical care practices. These data also highlight that nonglycemic risk factors, such as CVD risk factors, severe hypoglycemia, diabetic ketoacidosis, and lower socioeconomic status, may also play a role in DPN development.
引用
- Mizokami-Stout KR, Li Z, Foster NC, et al. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care. 2020. PMID: 32029635. doi:10.2337/dc19-1583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。